UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004690
Receipt number R000005580
Scientific Title The effect of tramadol on patients with septic shock caused by generalized peritonitis
Date of disclosure of the study information 2010/12/13
Last modified on 2010/12/08 18:01:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of tramadol on patients with septic shock caused by generalized peritonitis

Acronym

The effect of tramadol on patients with septic shock caused by generalized peritonitis

Scientific Title

The effect of tramadol on patients with septic shock caused by generalized peritonitis

Scientific Title:Acronym

The effect of tramadol on patients with septic shock caused by generalized peritonitis

Region

Japan


Condition

Condition

Sepsis

Classification by specialty

Anesthesiology Intensive care medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine the effect of perioperative administration of tramadol to patients with septic shock caused by generalized peritonitis on hemodynamics and dosage of vasopressor.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The norepinephrine requirement during and after surgery

Key secondary outcomes

Organ dysfunction score, infusion volume, urinary output, and cardiovascular drugs requirement


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Tramadol 2mg/kg is administered intramuscularly after induction of anesthesia. Since then, same dose of tramadol is administered iteratively every five hours until discharge from the intensive care unit or for up to 48 hours after surgery. Hemodynamic responses around tramadol administration, cardiovascular drug requirement, infusion volume, urine output, and organ dysfunction score is recorded.

Interventions/Control_2

Saline 0.04ml/kg is administered intramuscularly after induction of anesthesia. Since then, same dose of tramadol is administered iteratively every five hours until discharge from the intensive care unit or for up to 48 hours after surgery. Hemodynamic responses around saline administration, cardiovascular drug requirement, infusion volume, urine output, and organ dysfunction score is recorded.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

After obtaining written informed consent from the patients' next of kin, ASA physical status 1 - 3 patients with generalized peritonitis who are scheduled to undergo the surgery are prospectively enrolled in this study.
P1 A normal healthy patient
P2 A patient with mild systemic disease
P3 A patient with severe systemic disease
P4 A patient with severe systemic disease that is a constant threat to life
P5 A moribund patient who is not expected to survive without the operation
P6 A declared brain-dead patient whose organs are being removed for donor purposes

Key exclusion criteria

1) Age of younger than 18 years
2) Pregnancy
3) Allergy to scheduled drugs
4) Previous history of severe kidney and/or liver disease
5) Previous sulfonylurea use
6) Current use of anticonvulsant drugs
7) Inappropriate patients for study judged by the physicians

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Iranami

Organization

Japanese Red Cross Society Wakayama Medical Center

Division name

Department of Anesthesiology

Zip code


Address

Komatsubara-dori 4-20, Wakayama, Wakayama 640-8558, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Iranami

Organization

Japanese Red Cross Society Wakayama Medical Center

Division name

Department of Anesthesiology

Zip code


Address

Komatsubara-dori 4-20, Wakayama, Wakayama 640-8558, Japan

TEL

073-422-4171

Homepage URL


Email



Sponsor or person

Institute

Japanese Red Cross Society Wakayama Medical Center
Department of Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

日本赤十字社和歌山医療センター


Other administrative information

Date of disclosure of the study information

2010 Year 12 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2010 Year 12 Month 08 Day

Date of IRB


Anticipated trial start date

2010 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 12 Month 08 Day

Last modified on

2010 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005580


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name